CoChat
Sign Up
Cited by 52

The DOI matches its Crossref record.

Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS): What is destined for the atypical endometrial hyperplasia?

Sivridis, Efthimios, Giatromanolaki, Alexandra, Liberis, Vasilios, Koukourakis, Michael I.·2011·Autophagy
DOI 10.4161/auto.7.1.13947
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/auto.7.1.13947

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 60

  1. Klionsky DJ, Emr SD. Autophagy as a regulated path- way of cellular degradation. Science 2000; 290:1717-21.
  2. Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct 2002; 27:421-9.
  3. Shintani T, Klionsky DJ. Autophagy in health and dis- ease: a double-edged sword. Science 2004; 306:990-5.
  4. Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ 2005; 12:1542-52.
  5. Fujii S, Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, Kojima M, et al. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 2008; 99:1813-9.
  6. Martinet W, De Meyer GR, Andries L, Herman AG, Kockx MM. Detection of autophagy in tissue by stan- dard immunohistochemistry: possibilities and limita- tions. Autophagy 2006; 2:55-7.
  7. Martinet W, De Meyer GR, Andries L, Herman AG, Kockx MM. In situ detection of starvation-induced autophagy. J Histochem Cytochem 2006; 54:85-96.
  8. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homo- logue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19:5720-8.
  9. Kabeya Y, Mizushima N, Yamamoto A, Oshitani- Okamoto S, Ohsumi Y, Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 2004; 117:2805-12.
  10. Giatromanolaki A, Koukourakis MI, Harris AL, Polychronidis A, Gatter KC, Sivridis E. Prognostic relevance of LC3A autophagy patterns in colorectal adenocarcinomas. J Clin Pathol 2010; 63:867-72.
  11. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004; 15:1101-11.
  12. Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I, et al. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol 2007; 30:429-36.
  13. Bray F, Dos Santos Silva I, Moller H, Weiderpass E. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev 2005; 14:1132-42.
  14. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics 2009. CA Cancer J Clin 2009; 59:225-49.
  15. Warburg O. On respiratory impairment in cancer cells. Science 1956; 124:269-70.
  16. Weinhouse S. The Warburg hypothesis fifty years later. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1976; 87:115-26.
  17. Folkman J. What is the evidence that tumors are angio- genesis dependent? J Natl Cancer Inst 1990; 82:4-6.
  18. Giatromanolaki A, Sivridis E, Koukourakis MI. Tumour angiogenesis: vascular growth and survival. APMIS 2004; 112:431-40.
  19. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7:11-20.
  20. Izuishi K, Kato K, Ogura T, Kinoshita T, Esumi H. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res 2000; 60:6201-7.
  21. Esumi H, Izuishi K, Kato K, Hashimoto K, Kurashima Y, Kishimoto A, et al. Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5'-AMP-activated protein kinase-dependent manner. J Biol Chem 2002; 277:32791-8.
  22. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2:38-47.
  23. Cuervo AM. Autophagy: in sickness and in health. Trends Cell Biol 2004; 14:70-7.
  24. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation and tumorigenesis. Cancer Cell 2006; 10:51-64.
  25. Jin S, White E. Role of autophagy in cancer: manage- ment of metabolic stress. Autophagy 2007; 3:28-31.
  26. Webber JL, Young AR, Tooze SA. Atg9 trafficking in Mammalian cells. Autophagy 2007; 3:54-6.
  27. Sivridis E, Giatromanolaki A. Endometrial adenocar- cinoma: an apostasy from early views. Gynecol Oncol 2004; 95:772-3.
  28. Sivridis E, Giatromanolaki A. Endometrial adenocarci- noma: beliefs and scepticism. Int J Surg Pathol 2004; 12:99-105.
  29. Hoyer-Hansen M, Jaattela M. Autophagy: an emerging target for cancer therapy. Autophagy 2008; 4:574-80.
  30. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726-34.
  31. Hippert MM, O'Toole PS, Thorburn A. Autophagy in cancer: good, bad or both? Cancer Res 2006; 66:9349-51.
  32. de Medina P, Silvente-Poirot S, Poirot M. Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation. Autophagy 2009; 5:1066-7.
  33. Hoyer-Hansen M, Bastholm L, Mathiasen IS, Elling F, Jaattela M. Vitamin D analog EB1089 triggers dramat- ic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ 2005; 12:1297-309.
  34. Sivridis E, Fox H, Buckley CH. Endometrial carcino- ma: two or three entities? Int J Gynecol Cancer 1998; 8:183-8.
  35. Creasman WT. Announcement. FIGO stages-1988 revision. Gynecol Oncol 1989; 35:125-7.
  36. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study. Cancer 1995; 75:81-6.
  37. Lotocki RJ, Copeland LJ, DePetrillo AD, Muirhead W. Stage I endometrial adenocarcinoma: treatment results in 835 patients. Am J Obstet Gynecol 1983; 146:141-5.
  38. Carcinoma of the endometrium. ACOG Technical Bulletin Number 162-December 1991. Int J Gynaecol Obstet 1993; 40:255-61.
  39. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. International histological classification and typing of female genital tract tumors. New York: Springer-Verlag 1994.
  40. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1:3-25.
  41. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
  42. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
  43. Zaino RJ, Kurman RJ. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma. Semin Diagn Pathol 1988; 5:154-71.
  44. Zaino RJ, Kurman R, Herbold D, Gliedman J, Bundy BN, Voet R, et al. The significance of squamous dif- ferentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study. Cancer 1991; 68:2293-302.
  45. Abeler VM, Kjorstad KE. Endometrial adenocarci- noma with squamous cell differentiation. Cancer 1992; 69:488-95.
  46. Mutter GL. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol 2000; 76:287-90.
  47. Fox H, Buckley CH. The endometrial hyperpla- sias and their relationship to endometrial neoplasia. Histopathology 1982; 6:493-510.
  48. Sivridis E, Giatromanolaki A. Prognostic aspects on endometrial hyperplasia and neoplasia. Virchows Arch 2001; 439:118-26.
  49. Sivridis E, Giatromanolaki A. The endometrial hyper- plasias revisited. Virchows Arch 2008; 453:223-31.
  50. Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Muller-Holzner E, et al. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 1999; 23:1102-8.
  51. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007; 21:1621-35.
  52. Silverberg SG, De Giorgi LS. Clear cell carcinoma of the endometrium. Clinical, pathologic and ultrastruc- tural findings. Cancer 1973; 31:1127-40.
  53. Kurman RJ, Scully RE. Clear cell carcinoma of the endometrium: an analysis of 21 cases. Cancer 1976; 37:872-82.
  54. Abeler VM, Vergote IB, Kjorstad KE, Trope CG. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 1996; 78:1740-7.
  55. Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, McKee B, et al. Is there a difference in outcome between stage I-II endometrial cancer of pap- illary serous/clear cell and endometrioid FIGO Grade 3 cancer? Int J Radiat Oncol Biol Phys 2002; 54:79-85.
  56. Creasman WT, Kohler MF, Odicino F, Maisonneuve P, Boyle P. Prognosis of papillary serous, clear cell and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol 2004; 95:593-6.
  57. Melhem MF, Tobon H. Mucinous adenocarcinoma of the endometrium: a clinico-pathological review of 18 cases. Int J Gynecol Pathol 1987; 6:347-55.
  58. Deligdisch L, Holinka CF. Progesterone receptors in two groups of endometrial carcinoma. Cancer 1986; 57:1385-8.
  59. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Comparison of estrogen and progesterone receptor, Ki-67 and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, muci- nous, secretory and ciliated cell differentiation. Hum Pathol 1998; 29:924-31.
  60. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 2004; 444:213-23.

Cited by

Sorted by citations

Metadata

Authors
Sivridis, E., Giatromanolaki, A., Liberis, V., & Koukourakis, M. I.
Venue
Autophagy
Publisher
Informa UK Limited
Published
2011-01
Volume
7
Issue
1
Pages
74-82
ISSN
  • 1554-8627
  • 1554-8635
DOI
10.4161/auto.7.1.13947
Cited by
52
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review